Characteristic | |
---|---|
General | |
Age (years) (mean (SD)) | 67.2 (15.7) |
Female (n (%)) | 41 (56.2) |
NIHSS (median (IQR)) | 15.5 (13–19) |
IV tPA (n (%)) | 44 (60.3) |
Medical history (n (%)) | |
HTN | 50 (68.5) |
DM | 11 (22.9) |
CAD | 17 (23.3) |
HLD | 35 (48.0) |
Atrial fibrillation | 18 (24.7) |
Warfarin use | 6 (8.3) |
Aspirin use | 28 (38.9) |
Statin use | 27 (37.0) |
Antihypertensive agent use | 49 (67.1) |
Hyperglycemic agent use | 13 (17.8) |
Tobacco | 21 (29.2) |
Laboratory profile | |
INR (mean (SD)) | 1.14±0.23 |
Glucose (mean (SD)) | 138±45.2 |
Imaging characteristics | |
Good collaterals (n (%)) | 31 (40) |
LAv (mL) (median (IQR)) | 7.24 (2.2–8.8) |
DWIv (mL) (median (IQR)) | 15.39 (9.22–20.33) |
Outcomes (n (%)) | |
Recanalized | 32 (43.8) |
Mortality | 19 (27.5) |
mRS score≤2 | 24 (35.8) |
sICH | 7 (9.6) |
CAD, coronary artery disease; DM, diabetes mellitus; DWIv, diffusion restricted imaging volume; HLD, hyperlipidemia; HTN, hypertension; INR, international normalized ratio; LAv, leukoaraiosis volume; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; sICH, symptomatic intracranial hemorrhage; tPA, tissue plasminogen activator.